AI assistant
Sending…
Medivir — Major Shareholding Notification 2014
Sep 18, 2014
3177_iss_2014-09-18_c80a47c0-3673-4ed5-9d00-a42a3b95d1e5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Medivir Aktiebolag
Holder
Nordea Funds Ab
Instrument
| Instrument | Aktie SE0000273294 | |||
|---|---|---|---|---|
| Before the transaction | ||||
| Shares | 1,529,358 | |||
| Voting rights | 1,529,358 | |||
| Transaction | ||||
| Reason for major shareholding notification Share loan | ||||
| Date | 17/09/2014 | |||
| Limit for number of shares | 5 % | |||
| After the transaction | ||||
| Quantity | ||||
| Shares | 1,588,880 | |||
| Directly held voting rights | 1,588,880 | |||
| Indirectly held voting rights | 0 | |||
| Percentage | ||||
| Directly held shares | 5.08 % | |||
| Directly held voting rights | 4.27 % | |||
| Indirectly held voting rights | 0 % | |||
Resulting distribution of total holdings
| Percentage of voting |
|---|
| rights: |
Number of underlying
shares:
Shares
| Instruments - FITA Ch. 4, section 2, first | |||
|---|---|---|---|
| paragraph, line 2 | |||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
-
Physically settled
-
Cash settled
Total
Published
18/09/2014 10:08 Contact Name Leif Haglund Phone 08-57942051 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Medivir
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
AGM Information
2026
May 7
AGM Information
2026
May 7
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 2